Optomed Plc: Interim Report, January – March 2024
Optomed Plc Stock Exchange Release 7 May 2024 at 9.00, Helsinki Optomed Plc: Interim Report, January – March 2024 January – March 2024 · Revenue decreased by 4.4 percent to EUR 3.3 (3.5) million. · Devices segment revenue increased by 0.1 percent to EUR 0.9 (0.9) million. · Software segment revenue decreased by 5.9 percent to EUR 2.4 (2.6) million. · EBITDA and adjusted EBITDA amounted to EUR -0.6 (-0.5) million corresponding to -26.3 (-14.8) percent of revenue. · Outlook unchanged: Optomed expects its full year 2024 revenue to grow compared to 2023.